Teflurane
 | |
| Systematic (IUPAC) name | |
|---|---|
| 2-Bromo-1,1,1,2-tetrafluoroethane | |
| Clinical data | |
| Identifiers | |
| 124-72-1 | |
| None | |
| PubChem | CID 31300 |
| ChemSpider | 29040 |
| Chemical data | |
| Formula | C2HBrF4 |
| 180.927 g/mol | |
|
SMILES
| |
| |
Teflurane (INN, USAN, code name Abbott 16900) is a halocarbon drug which was investigated as an inhalational anesthetic but was never marketed.[1][2] Its clinical development was terminated due to a high incidence of cardiac arrhythmias in patients, similarly to the cases of halopropane and norflurane.[3]
See also
References
- ↑ Sanford L. Klein (1993). A glossary of anesthesia and related terminology. Springer-Verlag. ISBN 978-0-387-97831-4.
- ↑ Joseph Francis Artusio; Valentino D. B. Mazzia (1962). Practical anesthesiology. Mosby.
- ↑ T.H. Stanley; W.C. Petty (6 December 2012). Anesthesia, The Heart and the Vascular System: Annual Utah Postgraduate Course in Anesthesiology 1987. Springer Science & Business Media. pp. 185–. ISBN 978-94-009-3295-1.
| ||||||||||||||||||||||||||||||||||||||||||||||